Realcan Pharma and AWS Expand Partnership for Digital Transformation

China-based Realcan Pharmaceutical Group Co., Ltd (SHE: 002589) and Amazon Web Services (AWS) have agreed on a second phase partnership, with AWS becoming Realcan’s preferred cloud service provider to support its digital transformation. Financial details of the deal were not disclosed.

Building on a Strong Foundation
The two companies first partnered in 2020, and since then, AWS has enabled Realcan to develop a robust cloud presence, including 50 sets of enterprise application systems and more than 200 servers. During the second phase, AWS will assist Realcan in creating a “cloud-first” technical team and offer innovative business solutions. This includes implementing modern enterprise applications and micro-service transformation, as well as launching new projects and businesses such as a new quotation system, digital chronic disease management, and Internet hospitals.

Realcan’s Comprehensive Network
Realcan provides a national, comprehensive drug and device direct sales network, covering drug distribution, equipment, medical diagnostics, academic services, digital medical care, pharmaceutical logistics, traditional Chinese medicines, and more.-Fineline Info & Tech

Insight, China's Pharmaceutical Industry